AMLX

Health Care Sector Update for 03/14/2023: AMLX, RAPT, AGEN, XLV, IBB

Health care stocks were gaining premarket Tuesday. The Health Care Select Sector SPDR Fund (XLV) was 0.7% higher and the iShares Biotechnology ETF (IBB) was recently up 0.4%.

Amylyx Pharmaceuticals (AMLX) was over 17% higher after saying overnight its Q4 net loss narrowed to $0.65 per diluted share, compared with a loss of $4.10 a year earlier. Analysts polled by Capital IQ expected a per-share loss of $0.81.

RAPT Therapeutics (RAPT) was up more than 5% after it posted a Q4 loss of $0.64 per diluted share, wider than a loss of $0.61 a year earlier but narrower than a loss of $0.66 expected by analysts polled by Capital IQ.

Agenus (AGEN) was more than 9% higher after it posted a Q4 loss of $0.24 per share, narrowing from a loss of $0.26 a year earlier. Analysts polled by Capital IQ expected a loss of $0.22.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.